Literature DB >> 3985062

Risk factors and recurrent patterns in Stage I endometrial cancer.

P J DiSaia, W T Creasman, R C Boronow, J A Blessing.   

Abstract

Clinical Stage I carcinoma of the endometrium was evaluated in 222 patients. Twenty-five percent of patients were found to have pathologic findings thought to require postoperative external irradiation; of these, 20 of 57 (35%) had recurrence. During the 36- to 72-month follow-up period, only 14 of 165 (8.3%) treated only with operation (68 patients or 31%) or operation plus intracavitary radium (97 patients or 44%) manifested a recurrence. Furthermore, of all recurrences, 27 of the 34 (79%) were outside the pelvis. In these surgically staged cases, the absence of definable, demonstrable extrauterine disease was associated with a 7% recurrence rate versus a 43% recurrence rate if disease was found anywhere outside the uterus. Recurrence and death were correlated with other prognostic factors, which are outlined in this report.

Entities:  

Mesh:

Year:  1985        PMID: 3985062     DOI: 10.1016/0002-9378(85)90371-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  28 in total

1.  Lower uterine segment involvement is associated with poor outcomes in early-stage endometrioid endometrial carcinoma.

Authors:  Nora T Kizer; Feng Gao; Saketh Guntupalli; Premal H Thaker; Matthew A Powell; Paul J Goodfellow; David G Mutch; Israel Zighelboim
Journal:  Ann Surg Oncol       Date:  2010-12-22       Impact factor: 5.344

2.  Comprehensive surgical staging for endometrial cancer.

Authors:  Bunja Rungruang; Alexander B Olawaiye
Journal:  Rev Obstet Gynecol       Date:  2012

3.  Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a prospective randomized study with 11-year experience.

Authors:  Qi Lu; Haiyan Liu; Chongdong Liu; Shuzhen Wang; Shuhong Li; Shuli Guo; Junli Lu; Zhenyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-06       Impact factor: 4.553

4.  Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.

Authors:  Joyce N Barlin; Robert A Soslow; Megan Lutz; Qin C Zhou; Caryn M St Clair; Mario M Leitao; Alexia Iasonos; Martee L Hensley; Richard R Barakat; Xavier Matias-Guiu; Nadeem R Abu-Rustum
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

5.  The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.

Authors:  Praveen S Rathod; P N Shakuntala; V R Pallavi; Rajashekar Kundaragi; B Shankaranand; C R Vijay; K Uma Devi; Uttam D Bafna
Journal:  Indian J Surg Oncol       Date:  2014-03-28

6.  A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.

Authors:  Pamela T Soliman; Shannon N Westin; Shayan Dioun; Charlotte C Sun; Elizabeth Euscher; Mark F Munsell; Nicole D Fleming; Charles Levenback; Michael Frumovitz; Pedro T Ramirez; Karen H Lu
Journal:  Gynecol Oncol       Date:  2017-05-18       Impact factor: 5.482

Review 7.  Pathophysiology and management of endometrial hyperplasia and carcinoma.

Authors:  Y S Fu; J C Gambone; J S Berek
Journal:  West J Med       Date:  1990-07

8.  Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.

Authors:  Serra Akar; Zeliha Esin Çelik; Sıddıka Fındık; Tolgay Tuyan İlhan; Fedi Ercan; Çetin Çelik
Journal:  Int J Clin Oncol       Date:  2019-08-26       Impact factor: 3.402

9.  Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning.

Authors:  John M Boyle; Oana Craciunescu; Beverley Steffey; Jing Cai; Junzo Chino
Journal:  Brachytherapy       Date:  2014-01-16       Impact factor: 2.362

10.  Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.

Authors:  Christine H Kim; Fady Khoury-Collado; Emma L Barber; Robert A Soslow; Vicky Makker; Mario M Leitao; Yukio Sonoda; Kaled M Alektiar; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2013-10-04       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.